May 3, 2009
New Organizational Structures Required to Translate Basic Science into Clinical Application Says CRI Scientific Director
Voice of America®, the multimedia international broadcasting service funded by the U.S. government, has published an interview with Lloyd J. Old, M.D., director of the Cancer Research Institute Scientific Advisory Council, on the state of cancer research, its impact on cancer mortality, and promising immune-based therapeutic approaches now in development, including cancer vaccines and antibody therapies. In the interview, Dr. Old, who also directs the CRI/LICR Cancer Vaccine Collaborative, a global initiative to discover and develop the most effective approaches to cancer vaccination, discusses how the Collaborative's organizational structure allows it to circumvent financial and administrative barriers that inhibit or prevent bringing new discoveries into the clinic.
Read the article, in original Russian.
Read our English translation.
Contact: Brian Brewer, Director of Communications, Cancer Research Institute
(212) 688-7515 or bbrewer@cancerresearch.org
Lloyd J. Old, M.D.
Dr. Old is chairman of the Board of Directors of the Ludwig Institute for Cancer Research Ltd. Previously, he was director and chief executive officer of the Ludwig Institute. He has been associated with the Memorial Sloan-Kettering Cancer Center since 1958, first as a research fellow. He was appointed associate director of research in 1973 of Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and Allied Diseases and was named the William E. Snee Chair of Cancer Immunology in 1983. Old is one of the pioneers in tumor immunology, having made some of the most important contributions to that field from both the lab bench and the board room table. He is one of the most highly cited researchers in the field, and is an international award-winning scientific luminary who has helped to forge alliances among academic and industry interests in order to accelerate the scientifically prudent advancement of cancer vaccines.
For a more detailed biography of Dr. Old, visit:
http://www.cancerresearch.org/board/Lloyd-Old.html
For a description of Dr. Old's key scientific contributions, visit:
http://www.cancerresearch.org/Programs.aspx?id=2290
About the Cancer Research Institute
The Cancer Research Institute (CRI) is the world’s only non-profit organization dedicated exclusively to the support and coordination of scientific and clinical efforts that will lead to the immunological treatment, control, and prevention of cancer. Guided by a world-renowned Scientific Advisory Council that includes five Nobel Prize winners and thirty members of the National Academy of Sciences, CRI supports cutting-edge cancer research at top medical centers and universities throughout the world. The Cancer Research Institute is ushering in a new era of scientific progress, hastening the discovery of effective cancer vaccines and other immune-based therapies that are providing new hope to cancer patients.
The Cancer Research Institute has one of the lowest overhead expense ratios among non-profit organizations, with the majority of its resources going directly to the support of its science, medical, and research programs. CRI has earned the coveted four out of four stars from Charity Navigator, an 'A' grade for fiscal disclosure and efficiency from the American Institute of Philanthropy, and top marks from other charity watchdog organizations. www.cancerresearch.org
# # #